• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福平治疗葡萄球菌引起的骨与关节感染

Rifampicin in the treatment of osteoarticular infections due to staphylococci.

作者信息

Cluzel R A, Lopitaux R, Sirot J, Rampon S

出版信息

J Antimicrob Chemother. 1984 Jun;13 Suppl C:23-9. doi: 10.1093/jac/13.suppl_c.23.

DOI:10.1093/jac/13.suppl_c.23
PMID:6469888
Abstract

Rifampicin is a suitable drug for treating staphylococcal bone and articular infections, because high levels are obtained in the human tissues. The best oral dose is 600 mg 12 hourly. The serum levels range from 10 to 15 mg/l at the peak concentration and from 0.2 to 0.6 mg/l 8 h after oral administration of 600 mg. The ratio for cancellous bone/serum is 0.41 at 3 h and 0.39 at 12 h, and for cortical bone/serum is 0.20 at 3 h after a dose of 600 mg. In every case, tissue levels paralleled serum levels; cancellous bone levels are greater than the MIC of Staphylococcus aureus strains until 12 h after a dose of 600 mg. Rifampicin is always used in combination with another antibacterial substance. Results are excellent in most cases. The average duration of antibiotic treatment is 3 months for osteo-arthritis, 6 months for spondylitis and osteitis.

摘要

利福平是治疗葡萄球菌骨和关节感染的合适药物,因为它在人体组织中能达到较高浓度。最佳口服剂量是每12小时600毫克。口服600毫克后,峰值浓度时血清水平为10至15毫克/升,8小时后为0.2至0.6毫克/升。服用600毫克剂量后3小时,松质骨/血清比值为0.41,12小时时为0.39;皮质骨/血清比值在3小时时为0.20。在每种情况下,组织水平与血清水平平行;服用600毫克剂量后,直至12小时,松质骨水平均高于金黄色葡萄球菌菌株的最低抑菌浓度。利福平总是与另一种抗菌物质联合使用。大多数情况下效果良好。骨关节炎的抗生素治疗平均持续时间为3个月,脊柱炎和骨炎为6个月。

相似文献

1
Rifampicin in the treatment of osteoarticular infections due to staphylococci.利福平治疗葡萄球菌引起的骨与关节感染
J Antimicrob Chemother. 1984 Jun;13 Suppl C:23-9. doi: 10.1093/jac/13.suppl_c.23.
2
[Diffusion of rifampicin into spongy and compact bone tissue during total hip prosthesis operation].[全髋关节置换手术中利福平在松质骨和密质骨组织中的扩散]
Pathol Biol (Paris). 1983 May;31(5):438-41.
3
Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.口服克林霉素-利福平联合治疗葡萄球菌骨关节感染患者的克林霉素血清浓度显著降低。
J Infect. 2015 Aug;71(2):200-6. doi: 10.1016/j.jinf.2015.03.013. Epub 2015 Apr 30.
4
[Rifampicin diffusion in non-infected human bone (author's transl)].利福平在未感染人骨中的扩散(作者译)
Ann Microbiol (Paris). 1977 Aug-Sep;128(2):229-36.
5
[Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].[复方新诺明联合利福平治疗葡萄球菌性骨关节感染]
Enferm Infecc Microbiol Clin. 1997 Jan;15(1):10-3.
6
[Rifampicin in the treatment of Staphylococcus arthritis].[利福平治疗葡萄球菌性关节炎]
Pathol Biol (Paris). 1983 May;31(5):442-5.
7
Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.口服克林霉素联合利福平治疗葡萄球菌性骨与关节感染的疗效
Scand J Infect Dis. 2011 Dec;43(11-12):962-7. doi: 10.3109/00365548.2011.608082. Epub 2011 Sep 15.
8
[The bactericidal power of antibiotic combinations. Application in the treatment of osteo-articular infections due to Staphylococcus aureus (author's transl)].
Nouv Presse Med. 1978 Oct 21;7(36):3217-22.
9
Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.在治疗药物监测下,使用利奈唑胺和利福平联合治疗耐甲氧西林金黄色葡萄球菌骨髓炎取得成功。
J Infect Chemother. 2016 May;22(5):331-4. doi: 10.1016/j.jiac.2015.11.012. Epub 2015 Dec 28.
10
Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.左氧氟沙星和利福平在骨关节感染中的药代动力学和药效学研究。
Med Mal Infect. 2012 Sep;42(9):414-20. doi: 10.1016/j.medmal.2012.07.018. Epub 2012 Sep 1.

引用本文的文献

1
Model-Informed Precision Dosing of Antibiotics in Osteoarticular Infections.骨关节炎感染中抗生素的模型指导精准给药
Infect Drug Resist. 2022 Jan 11;15:99-110. doi: 10.2147/IDR.S332366. eCollection 2022.
2
Dynamic PET-facilitated modeling and high-dose rifampin regimens for orthopedic implant-associated infections.动态PET辅助建模及高剂量利福平方案治疗骨科植入物相关感染
Sci Transl Med. 2021 Dec;13(622):eabl6851. doi: 10.1126/scitranslmed.abl6851. Epub 2021 Dec 1.
3
Synthesis and characterization of antibacterial drug loaded β-tricalcium phosphate powders for bone engineering applications.
载抗菌药物β-磷酸三钙粉末的合成与表征及其在骨组织工程中的应用。
J Mater Sci Mater Med. 2020 Jan 21;31(2):16. doi: 10.1007/s10856-019-6356-1.
4
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.抗菌药物在骨组织中的渗透:药代动力学、药效学及生物分析学考量
Clin Pharmacokinet. 2009;48(2):89-124. doi: 10.2165/00003088-200948020-00002.
5
Use of aminoglycosides in treatment of infections due to intracellular bacteria.氨基糖苷类药物在治疗细胞内细菌感染中的应用。
Antimicrob Agents Chemother. 2001 Nov;45(11):2977-86. doi: 10.1128/AAC.45.11.2977-2986.2001.